Vitanova Biomedical is a privately-held San Antonio, Texas-based biotechnology company that aims to improve the lives of cancer patients and the healthcare professionals who care for them through the development and commercialization of their novel LAIA platform cancer therapy. Vitanova Biomedical is currently pursuing preclinical evidence to support progress toward regulatory clearance and market commercialization.